A pilot study of peripheral blood stem cell harvest using bortezomib in combination with granulocyte colony stimulating factor (G-CSF)
Phase 2
- Conditions
- Patients with multiple myeloma who are eligible for transplantation
- Registration Number
- JPRN-UMIN000022421
- Lead Sponsor
- Fukuoka University Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are hypersensitive for either bortezomib or G-CSF Patients with grade 2 or higher peripheral neuropathy Patients with double cancer Patients with psychological disorder Patients with interstitial pneumonia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients who are able to obtain more than 1.5 x10^6/kg of CD34-positive cells at one apheresis
- Secondary Outcome Measures
Name Time Method Safety